Company Plans to Develop Proprietary Nanocomposite Balloon for Drug Delivery
DALLAS, Aug. 11, 2015 /PRNewswire-iReach/ -- Rosellini Scientific, LLC ("RS" or "the Company") an operational investment company, announced today that it received a Fast Track SBIR to develop